CA Patent

CA2721133C — Low-dose doxepin formulations and methods of making and using the same

Assigned to Currax Pharmaceuticals LLC · Expires 2018-11-06 · 8y expired

What this patent protects

The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.

USPTO Abstract

The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.

Drugs covered by this patent

Patent Metadata

Patent number
CA2721133C
Jurisdiction
CA
Classification
—
Expires
2018-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Currax Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.